HA
CELG

Highland Associates’s Celgene Corp CELG Stock Holding History

Highland Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$21.1M Hold
228,702
– – 3.02% 6
2019
Q1 		$21.6M Buy
+228,702
New +$20M 3.06% 4

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highland Associates's CELG Position: Q2 2019 in Review

Highland Associates held its Celgene Corp (CELG) position steady in Q2 2019 at 228,702 shares worth $21.1M. The position accounts for 3.02% of the portfolio, ranked #6.

Highland Associates first reported a position in CELG in Q1 2019 and has held it in 2 quarters since. The position peaked at $21.6M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Highland Associates held 228,702 shares of Celgene Corp worth $21.1M as of Q2 2019.
  • Highland Associates left its Celgene Corp share count unchanged in Q2 2019.
  • Celgene Corp made up 3.02% of Highland Associates's portfolio in Q2 2019, its #6 holding.
  • Highland Associates first reported a position in Celgene Corp in Q1 2019 and has held it in 2 quarters since.
  • Highland Associates's Celgene Corp position peaked at $21.6M in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Highland Associates's 13F filing for Q2 2019, filed 8 Aug 2019.